ES2177962T3 - Sistema de administracion transdermica de reducido espesor de aplicacion y elevada flexibilidad, y proceso de fabricacion del mismo. - Google Patents

Sistema de administracion transdermica de reducido espesor de aplicacion y elevada flexibilidad, y proceso de fabricacion del mismo.

Info

Publication number
ES2177962T3
ES2177962T3 ES97914228T ES97914228T ES2177962T3 ES 2177962 T3 ES2177962 T3 ES 2177962T3 ES 97914228 T ES97914228 T ES 97914228T ES 97914228 T ES97914228 T ES 97914228T ES 2177962 T3 ES2177962 T3 ES 2177962T3
Authority
ES
Spain
Prior art keywords
high flexibility
same
manufacturing process
application thickness
transdermal administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97914228T
Other languages
English (en)
Inventor
Kleinsorgen Reinhard Von
Kleinsorgen Britta Von
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LTS Lohmann Therapie Systeme AG
Original Assignee
LTS Lohmann Therapie Systeme AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19708674A external-priority patent/DE19708674C2/de
Application filed by LTS Lohmann Therapie Systeme AG filed Critical LTS Lohmann Therapie Systeme AG
Application granted granted Critical
Publication of ES2177962T3 publication Critical patent/ES2177962T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Materials For Medical Uses (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

UN SISTEMA TERAPEUTICO TRANSDERMAL QUE EMITE SUSTANCIAS ACTIVAS A UN SUSTRATO, SE CARACTERIZA PORQUE EL SISTEMA ESTA COMPUESTO POR UNA CAPA PORTADORA (1) PROVISTA DE UNA CAPA DE SEPARACION (2), UNA PELICULA (3) QUE CONTIENE LA SUSTANCIA ACTIVA Y UNA CAPA DE PROTECCION (4) EMISORA, ESTANDO FORMADA LA CAPA DE SEPARACION (2) DE UN MATERIAL, CUYO COMPUESTO PUEDE SER NEUTRALIZADO CON LA PELICULA (3). TALES SISTEMAS PUEDEN SER PRODUCIDOS DESDE EL PUNTO DE VISTA DE LA TECNICA DE IMPRESION CON UN ESPESOR DE APLICACION PEQUEÑO Y UNA ELEVADA FLEXIBILIDAD, PUDIENDO PREVERSE COMO ALTERNATIVA AL COMPLEJO DE CAPA PORTADORA/CAPA DE SEPARACION, UN SUSTRATO DE EMISION. UN PROCESO DE IMPRESION QUE LIMITA LA ZONA QUE CONTIENE LA SUSTANCIA ACTIVA SOBRE LA SUPERFICIE DE APLICACION, REDUCE LOS PROBLEMAS DE EVACUACION DE LA MISMA.
ES97914228T 1996-03-25 1997-03-12 Sistema de administracion transdermica de reducido espesor de aplicacion y elevada flexibilidad, y proceso de fabricacion del mismo. Expired - Lifetime ES2177962T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19611684 1996-03-25
DE19708674A DE19708674C2 (de) 1996-03-25 1997-03-04 Transdermales therapeutisches System mit einer wirkstoffhaltigen Filmschicht und einer löslichen Trennschicht, sowie ein Verfahren zu dessen Herstellung

Publications (1)

Publication Number Publication Date
ES2177962T3 true ES2177962T3 (es) 2002-12-16

Family

ID=26024096

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97914228T Expired - Lifetime ES2177962T3 (es) 1996-03-25 1997-03-12 Sistema de administracion transdermica de reducido espesor de aplicacion y elevada flexibilidad, y proceso de fabricacion del mismo.

Country Status (17)

Country Link
US (1) US6165499A (es)
EP (1) EP0889723B1 (es)
JP (1) JP4086317B2 (es)
CN (1) CN1219126A (es)
AT (1) ATE218328T1 (es)
AU (1) AU728120B2 (es)
CZ (1) CZ306398A3 (es)
DK (1) DK0889723T3 (es)
ES (1) ES2177962T3 (es)
HU (1) HUP9902673A3 (es)
IL (1) IL126251A (es)
NO (1) NO984458L (es)
NZ (1) NZ332033A (es)
PL (1) PL329196A1 (es)
PT (1) PT889723E (es)
SK (1) SK130298A3 (es)
WO (1) WO1997035564A1 (es)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5968547A (en) 1997-02-24 1999-10-19 Euro-Celtique, S.A. Method of providing sustained analgesia with buprenorphine
DE19728517C2 (de) * 1997-07-04 1999-11-11 Sanol Arznei Schwarz Gmbh TTS zur Verabreichung von Sexualsteroidhormonen und Verfahren zu seiner Herstellung
DE19728516C2 (de) * 1997-07-04 1999-11-11 Sanol Arznei Schwarz Gmbh TTS zur Verabreichung von Levonorgestrel und gegebenenfalls Estradiol
DE29823343U1 (de) * 1998-03-20 1999-07-15 Schwarz Pharma Ag, 40789 Monheim Transdermales Therapeutisches System (TTS) Oxybutynin enthaltend
DE19826592A1 (de) * 1998-06-15 1999-12-16 Lohmann Therapie Syst Lts Verfahren zur Herstellung eines aus einzelnen Schichten bestehenden Laminats
KR100594666B1 (ko) * 1999-03-18 2006-07-03 에르테에스 로만 테라피-시스테메 아게 경피적 치료 시스템 및 그 제조방법
US7063859B1 (en) 1999-04-28 2006-06-20 Noven Pharmaceuticals, Inc. Barrier film lined backing layer composition and method for topical administration of active agents
DE19954420A1 (de) * 1999-11-12 2001-05-31 Lohmann Therapie Syst Lts Zubereitung, bestehend aus einer film-, folien- oder oblatenförmigen Darreichungsform mit zweischichtigem Aufbau und integrierter Kennzeichnung
US6783294B2 (en) 2000-02-14 2004-08-31 Johnson & Johnson Consumer Companies, Inc. Solid cleanser holder
US6607739B1 (en) 2000-02-14 2003-08-19 Johnson & Johnson Consumer Companies, Inc. Dispensing article
USRE44145E1 (en) 2000-07-07 2013-04-09 A.V. Topchiev Institute Of Petrochemical Synthesis Preparation of hydrophilic pressure sensitive adhesives having optimized adhesive properties
KR20020035398A (ko) * 2000-11-06 2002-05-11 김윤 수지(手指)용 진통 소염 경피투여제
US6479076B2 (en) * 2001-01-12 2002-11-12 Izhak Blank Nicotine delivery compositions
US8206738B2 (en) 2001-05-01 2012-06-26 Corium International, Inc. Hydrogel compositions with an erodible backing member
EP1390085B1 (en) 2001-05-01 2009-08-05 A.V. Topchiev Institute of Petrochemical Synthesis Hydrogel compositions
US20050113510A1 (en) 2001-05-01 2005-05-26 Feldstein Mikhail M. Method of preparing polymeric adhesive compositions utilizing the mechanism of interaction between the polymer components
US6803420B2 (en) 2001-05-01 2004-10-12 Corium International Two-phase, water-absorbent bioadhesive composition
US8541021B2 (en) * 2001-05-01 2013-09-24 A.V. Topchiev Institute Of Petrochemical Synthesis Hydrogel compositions demonstrating phase separation on contact with aqueous media
US8840918B2 (en) 2001-05-01 2014-09-23 A. V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences Hydrogel compositions for tooth whitening
US20050215727A1 (en) 2001-05-01 2005-09-29 Corium Water-absorbent adhesive compositions and associated methods of manufacture and use
CA2449293A1 (en) * 2001-06-18 2002-12-27 The Procter & Gamble Company Cosmetic compositions comprising discrete color domains and associated methods
US20030003065A1 (en) * 2001-06-18 2003-01-02 The Procter & Gamble Company Cosmetic compositions exhibiting characteristic first derivative spectral curves and associated methods
US20030054025A1 (en) * 2001-09-14 2003-03-20 3M Innovative Properties Company Non-contact printing method for making a medical pressure sensitive adhesive article
US20030097111A1 (en) * 2001-11-08 2003-05-22 Catarina Lundin Absorbent product
JP2005528359A (ja) * 2002-03-20 2005-09-22 ユーロ−セルティーク エス．エイ． うつ病の治療のためのブプレノルフィンの投与方法
EP1795189A3 (en) * 2002-03-20 2007-08-15 Euro-Celtique S.A. Method of administering buprenorphine to treat depression
GB0213437D0 (en) * 2002-06-12 2002-07-24 Univ Cranfield Temporary tattoos: A novel vehicle for skin testing
US20040147534A1 (en) * 2003-01-23 2004-07-29 Foote Mary Ann Topical composition and method for treating occlusive wounds
US8790689B2 (en) 2003-04-30 2014-07-29 Purdue Pharma L.P. Tamper resistant transdermal dosage form
CA2522529C (en) 2003-04-30 2015-10-20 Purdue Pharma L.P. Tamper resistant transdermal dosage form
EP1498133A1 (en) 2003-07-18 2005-01-19 Aventis Pharma Deutschland GmbH Use of a pak inhibitor for the treatment of a joint disease
CA2524122C (en) * 2003-07-25 2010-11-16 Lts Lohmann Therapie-Systeme Ag Wafer fixing and marking
DE10340428B4 (de) * 2003-09-02 2015-02-12 Acino Ag Opioides Analgetikum enthaltende transdermale Formulierung
EP1531333A1 (en) 2003-11-12 2005-05-18 Aventis Pharma Deutschland GmbH Method for the identification of a risk for a thrombogenic disorder by determining the TAFI-lle347 polymorphism
DE10361306A1 (de) * 2003-12-24 2005-07-28 Lts Lohmann Therapie-Systeme Ag Wundauflage und Wundschnellverband mit einem vasokonstriktorischen Inhaltsstoff, sowie Herstellungsverfahren hierfür
AU2005210637B2 (en) 2004-01-30 2010-09-16 A.V. Topchiev Institute Of Petrochemical Synthesis Rapidly dissolving film for delivery of an active agent
EP1602365A1 (en) * 2004-03-03 2005-12-07 Switch Biotech Aktiengesellschaft Pharmaceutical composition for topical use in form of xerogels or films and methods for production
DE102004019916A1 (de) * 2004-04-21 2005-11-17 Grünenthal GmbH Gegen Missbrauch gesichertes wirkstoffhaltiges Pflaster
EP1740617B1 (en) 2004-04-23 2013-10-16 BUNDESREPUBLIK DEUTSCHLAND letztvertreten durch das Robert Koch-Institut vertreten durch seinen Präsidenten Method for the treatment of t cell mediated conditions by depletion of icos-positive cells in vivo
US20050281757A1 (en) * 2004-06-17 2005-12-22 Sayed Ibrahim Oral care film
CA2576158C (en) 2004-08-05 2020-10-27 Corium International, Inc. Adhesive composition
AU2006222204B2 (en) 2005-03-11 2012-09-27 Sanofi-Aventis Use of MGC4504
US20060222693A1 (en) * 2005-03-30 2006-10-05 Silguero Kandy M Transdermal patch bearing a decorative image
US20060280809A1 (en) * 2005-06-14 2006-12-14 Leshchiner Adele K Anti-infective iodine based compositions for otic and nasal use
DE102005048898A1 (de) 2005-10-12 2007-04-19 Sanofi-Aventis Deutschland Gmbh EGLN2-Varianten und ihre Verwendung bei der Vorbeugung oder Behandlung thromboembolischer Erkrankungen und koronarer Herzerkrankungen
RU2008124805A (ru) * 2005-11-21 2009-12-27 Шеринг-Плоу Лтд. (CH) Фармацевтические композиции, содержащие бупренорфин
EP1795609A1 (en) 2005-12-06 2007-06-13 Sanofi-Aventis Deutschland GmbH Method for the diagnosis and treatment of cardiovascular diseases
US20090208545A1 (en) * 2008-02-20 2009-08-20 Carter-Lyde Nicole B System and method for providing medicinal treatment
EP2105742A1 (en) 2008-03-26 2009-09-30 Sanofi-Aventis Use of cathepsin C
AU2009264237B2 (en) 2008-06-27 2016-04-14 Meta-Iq Aps Inhibitors of carnitin-palmitoyl-transferase-1 for the treatment and prevention of disorders caused by delipidation of neural tissue
EP2387394B1 (en) 2009-01-14 2018-05-02 Corium International, Inc. Transdermal administration of tamsulosin
EP2293072A1 (en) 2009-08-31 2011-03-09 Sanofi-Aventis Use of cathepsin H
TW201239097A (en) 2010-12-17 2012-10-01 Sanofi Sa MiRNAs in joint disease
TW201238974A (en) 2010-12-17 2012-10-01 Sanofi Sa MiRNAs in joint disease
TW201241179A (en) 2010-12-17 2012-10-16 Sanofi Sa MiRNAs in joint disease
UY33807A (es) 2010-12-17 2012-07-31 Sanofi Sa miRNAs como indicadores del estado tisular o de enfermedades como osteoartritis
EP2578088A1 (en) 2011-10-06 2013-04-10 Nestec S.A. Edible web comprising microorganisms
AU2012385956B2 (en) 2012-07-23 2017-03-30 Crayola, Llc Dissolvable films and methods of using the same
JP2017510474A (ja) * 2013-12-31 2017-04-13 ジョンソン・アンド・ジョンソン・コンシューマー・インコーポレイテッド インテグラルフィルム製品を形成するための方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3637224A (en) * 1969-02-27 1972-01-25 Fedders Corp Annular sealing ring
DE2908432A1 (de) * 1979-03-05 1980-09-11 Volkswagenwerk Ag Waermepumpen-antriebsaggregat mit einem kompressor und einer brennkraftmaschine
US4624665A (en) * 1984-10-01 1986-11-25 Biotek, Inc. Method of transdermal drug delivery
CH674618A5 (es) * 1987-04-02 1990-06-29 Ciba Geigy Ag
US4915950A (en) * 1988-02-12 1990-04-10 Cygnus Research Corporation Printed transdermal drug delivery device
US5064422A (en) * 1990-10-18 1991-11-12 Bertek, Inc. Twin patch applicator
CA2078961A1 (en) * 1992-04-21 1993-10-22 John Wick Two-hand pouch patch application
DE69625549T2 (de) * 1995-06-27 2003-05-15 Kao Corp., Tokio/Tokyo Pflaster mit wasserlöslicher Klebeschicht
US5843472A (en) * 1997-02-28 1998-12-01 Cygnus, Inc. Transdermal drug delivery sytem for the administration of tamsulosin, and related compositions and methods of use

Also Published As

Publication number Publication date
AU728120B2 (en) 2001-01-04
DK0889723T3 (da) 2002-09-23
ATE218328T1 (de) 2002-06-15
HUP9902673A3 (en) 2001-04-28
JP4086317B2 (ja) 2008-05-14
NZ332033A (en) 1999-09-29
NO984458D0 (no) 1998-09-24
NO984458L (no) 1998-11-24
PT889723E (pt) 2002-11-29
SK130298A3 (en) 1999-03-12
JP2002504084A (ja) 2002-02-05
AU2155597A (en) 1997-10-17
WO1997035564A1 (de) 1997-10-02
EP0889723A1 (de) 1999-01-13
HUP9902673A2 (hu) 2000-10-28
CZ306398A3 (cs) 1999-01-13
IL126251A (en) 2003-06-24
IL126251A0 (en) 1999-05-09
EP0889723B1 (de) 2002-06-05
PL329196A1 (en) 1999-03-15
US6165499A (en) 2000-12-26
CN1219126A (zh) 1999-06-09

Similar Documents

Publication Publication Date Title
ES2177962T3 (es) Sistema de administracion transdermica de reducido espesor de aplicacion y elevada flexibilidad, y proceso de fabricacion del mismo.
ES278091Y (es) Una cinta adhesiva de seguridad
AU579794B2 (en) Medicinal self-adhesive plaster
ES2044246T3 (es) Medicamentos con liberacion controlada del producto activo.
MX173088B (es) Material compuesto adhesivo sensible a la presion con sistema de suministro
ES2195323T3 (es) Articulo de autolimpieza activada fotocataliticamente y metodo de hacerlo.
PT973497E (pt) Dispositivo transportador farmaceutico adequado para administracao de compostos farmaceuticos a superficies mucosas
CA2329128A1 (en) Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces
ES2092025T3 (es) Membrana impermeabilizante.
ES2167073T3 (es) Articulos absorbentes.
ES2100391T3 (es) Articulo absorbente.
ES2055692T3 (es) Sistema terapeutico en forma plana, procedimiento para su preparacion y su empleo.
AR009516A1 (es) Un dispositivo de parche de matriz adhesiva sensible a la presion, un metodo para preparar dicho dispositivo y un metodo para emplear dichodispositivo en el suministro transdermico de una droga.
UY23527A1 (es) Metodo para revestir sustratos de vidrio
ES2139689T3 (es) Estructura de envasado de lamina adhesiva sensible a la presion y que contiene farmaco.
KR840003468A (ko) 전 사 체
YU49490A (sh) Postupak za izradu flastera kao transdermalnog sistema za davanje aktivnih materija na koži sa odavanjem aktivne materije kao i primena
MX9102731A (es) Cinta adhesiva separable.
BR9509010A (pt) Estrutura de adesivo sensível á pressão com múltiplas camadas
AU3268689A (en) Transdermal monolith systems
ES2166769T3 (es) Comprimido farmaceutico de liberacion controlada que presenta forma lenticular.
AR017026A1 (es) Dispositivo de liberacion ininterrumpida de drogas
BR0103838A (pt) Artigo absorvente com folha de dorso tendo filamentos contìnuos
PE58999A1 (es) Tabletas de oxacarbazepina recubiertas de pelicula
ES2166050T3 (es) Pelicula con una capa de substrato que contiene agente antibloqueador.